B Cell Receptor Signaling Pathway Mutation as Prognosis Predictor of Immune Checkpoint Inhibitors in Lung Adenocarcinoma by Bioinformatic Analysis
Anqi Lin,1,* Jianbo Fang,1,* Quan Cheng,2,3 Zaoqu Liu,4 Peng Luo,1 Jian Zhang1 1Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, People’s Republic of China; 2Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan,...
Kaydedildi:
| Asıl Yazarlar: | , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2022-09-01
|
| Seri Bilgileri: | Journal of Inflammation Research |
| Konular: | |
| Online Erişim: | https://www.dovepress.com/b-cell-receptor-signaling-pathway-mutation-as-prognosis-predictor-of-i-peer-reviewed-fulltext-article-JIR |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|